BioTelemetry (BEAT) Tops Q4 EPS by 4c

BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.15, $0.04 better than the analyst estimate of $0.11. Revenue for the quarter came in at $46.8 million versus the consensus estimate of $45.89 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does